Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Sebina, Ismail ^d   Biraro, Irene A ^a,b   Dockrell, Hazel M ^c   Elliott, Alison M ^a,b,c   Cose, Stephen ^a,c  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN AG85A; ANTIGEN PPD; BACTERIAL ANTIGEN; BIOLOGICAL MARKER; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOBLAST; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HUMAN; HUMAN CELL; LATENT TUBERCULOSIS; MEMORY CELL; MIDDLE AGED; PERIPHERAL LYMPHOCYTE; PLASMABLAST; TUBERCULOSIS; UGANDA; YOUNG ADULT; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; ENDEMIC DISEASE; IMMUNOLOGY; METABOLISM;

ADOLESCENT; ADULT; B-LYMPHOCYTES; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; ENDEMIC DISEASES; HUMANS; LATENT TUBERCULOSIS; MIDDLE AGED; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 84906993087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106796     Document Type: Article

References (38)

1. Young DB, Gideon HP, Wilkinson RJ (2009) Eliminating latent tuberculosis. Trends Microbiol 17: 183-188.
2. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
3. Lin PL, Flynn JL (2010) Understanding latent tuberculosis: A moving target. J Immunol 185: 15-22.
4. Sridhar S, Pollock K, Lalvani A (2011) Redefining latent tuberculosis. Future Microbiol 6: 1021-1035.
5. Ottenhoff TH, Ellner JJ, Kaufmann SH (2012) Ten challenges for TB biomarkers. Tuberculosis (Edinb) 92 Suppl 1: S17-S20.
6. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
7. Maertzdorf J, Weiner J 3rd, Kaufmann SH (2012) Enabling biomarkers for tuberculosis control. Int J Tuberc Lung Dis 16: 1140-1148.
8. Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, et al. (2013) Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 13: 362-372.
9. Whitworth HS, Aranday-Cortes E, Lalvani A (2013) Biomarkers of tuberculosis: A research roadmap. Biomark Med 7: 349-362.
10. Pai M (2010) Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 8: 242; author reply 242.
11. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
12. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31: 475-527.
13. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
14. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, et al. (2013) Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 207: 18-29.
15. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG, et al. (2012) Identification of biomarkers for tuberculosis disease using a novel dual-color RTMLPA assay. Genes Immun 13: 71-82.
16. Kozakiewicz L, Phuah J, Flynn J, Chan J (2013) The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol 783: 225-250.
17. Maglione PJ, Chan J (2009) How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 39: 676-686.
18. Torrado E, Fountain JJ, Robinson RT, Martino CA, Pearl JE, et al. (2013) Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse. PLoS One 8: e61681.
19. Kozakiewicz L, Chen Y, Xu J, Wang Y, Dunussi-Joannopoulos K, et al. (2013) B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog 9: e1003472.
20. Phuah JY, Mattila JT, Lin PL, Flynn JL (2012) Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol 181: 508-514.
21. Zhang M, Zheng X, Zhang J, Zhu Y, Zhu X, et al. (2012) CD19(+)CD1d(+) CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cell Immunol 274: 89-97.
22. Sebina I, Cliff JM, Smith SG, Nogaro S, Webb EL, et al. (2012) Long-lived memory B-cell responses following BCG vaccination. PLoS One 7: e51381.
23. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, et al. (2005) Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105: 1614-1621.
24. Blanchard-Rohner G, Pulickal AS, Jol-van der Zijde CM, Snape MD, Pollard AJ (2009) Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood 114: 4998-5002.
25. Kelly DF, Pollard AJ, Moxon ER (2005) Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 294: 3019-3023.
26. Rosado MM, Scarsella M, Pandolfi E, Cascioli S, Giorda E, et al. (2011) Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur J Immunol 41: 1800-1808.
27. Tarlinton D, Radbruch A, Hiepe F, Dorner T (2008) Plasma cell differentiation and survival. Curr Opin Immunol 20: 162-169.
28. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199- 2202.
29. Pinna D, Corti D, Jarrossay D, Sallusto F, Lanzavecchia A (2009) Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 39: 1260-1270.
30. Amanna IJ, Carlson NE, Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357: 1903-1915.
31. Lalvani A, Richeldi L, Kunst H (2005) Interferon gamma assays for tuberculosis. Lancet Infect Dis 5: 322-324; author reply 325-327.
32. Khan IH, Ravindran R, Yee J, Ziman M, Lewinsohn DM, et al. (2008) Profiling antibodies to Mycobacterium tuberculosis by multiplex microbead suspension arrays for serodiagnosis of tuberculosis. Clin Vaccine Immunol 15: 433-438.
33. Raqib R, Mondal D, Karim MA, Chowdhury F, Ahmed S, et al. (2009) Detection of antibodies secreted from circulating Mycobacterium tuberculosisspecific plasma cells in the diagnosis of pediatric tuberculosis. Clin Vaccine Immunol 16: 521-527.
34. Mallone R, Mannering SI, Brooks-Worrell BM, Durinovic-Bello I, Cilio CM, et al. (2011) Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol 163: 33-49.
35. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL (2000) Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories. Clin Diagn Lab Immunol 7: 352-359.
36. Kyu SY, Kobie J, Yang H, Zand MS, Topham DJ, et al. (2009) Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J Immunol Methods 340: 42-47.
37. Truck J, Mitchell R, Thompson AJ, Morales-Aza B, Clutterbuck EA, et al. (2014) Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot: Variability of the memory B cell ELISpot assay. Hum Vaccin Immunother 10.
38. Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, et al. (2013) Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One 8: e63170.